Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies
暂无分享，去创建一个
J. Burke | J. Reeves | I. Flinn | B. Cheson | P. Zinzani | M. Davids | J. Pagel | E. Derenzini | T. Phillips | O. O’Connor | D. Brander | N. Ghosh | J. Chavez | Y. Hsu | R. Pettengell | P. Caimi | J. Essell | E. Lech-Maranda | W. Jurczak | F. Samaniego | J. Sharman | T. Fenske | L. Leslie | J. Allan | P. Sportelli | R. Agajanian | M. Patel | H. Miskin | C. Cheah | G. Fonseca | M. Weiss | W. Knopińska‐Posłuszny